Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

19%

4 trials in Phase 3/4

Results Transparency

5%

1 of 19 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (6)
P 1 (2)
P 2 (1)
P 3 (1)
P 4 (3)

Trial Status

Completed19
Active Not Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT06647797Not ApplicableCompleted

Enhancing Communication on Relationship Preservation, Safer Conception and PrEP to Promote HIV Testing in Uganda

NCT03048669Not ApplicableCompleted

Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo

NCT05652400Active Not Recruiting

HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia

NCT04468399Completed

Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-Malawi

NCT04170374Completed

Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-South Africa

NCT04470011Completed

Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-Zambia

NCT05850728Phase 1Completed

First in Human Study of TLC-ART 101 (ACTU 2001)

NCT05592613Phase 3Completed

Next Generation Ingestible Sensors for Medication Adherence Measurement

NCT02086630Phase 1Completed

Timely Initiation of HIV Antiretroviral Therapy Among Those Who Delay/Decline

NCT02060162Completed

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

NCT03315013Not ApplicableCompleted

Revised Simplified Algorithm for Treatment Eligibility for HIV (SLATEII)

NCT04311957Phase 4Unknown

Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults

NCT02995824Completed

Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients

NCT02756949Not ApplicableCompleted

Smart Linkage-to-HIV Care Via a Smartphone App

NCT03160105Phase 4Completed

Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV)

NCT03367130Not ApplicableCompleted

Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal

NCT00958100Phase 2Completed

Raltegravir Switch for Toxicity or Adverse Events

NCT01645865Completed

Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost

NCT01459575CompletedPrimary

Unboosted Atazanavir as Initial ART Therapy in China

NCT00405171Phase 4Completed

Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia

Scroll to load more

Research Network

Activity Timeline